astragaloside a has been researched along with Cryptogenic Fibrosing Alveolitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, WF; Chen, ZW; Tan, KY; Wang, M; Yuan, S; Zhou, SC; Zuo, B | 1 |
| Cai, X; Qian, Q; Qian, W; Tian, L; Zhang, W | 1 |
2 other study(ies) available for astragaloside a and Cryptogenic Fibrosing Alveolitis
| Article | Year |
|---|---|
Integrating Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanism of Astragaloside IV in Treating Bleomycin-Induced Pulmonary Fibrosis.
Topics: Animals; Bleomycin; Epithelial-Mesenchymal Transition; Idiopathic Pulmonary Fibrosis; Mice; Molecular Docking Simulation; Network Pharmacology | 2023 |
Metastasis-associated protein 1 promotes epithelial-mesenchymal transition in idiopathic pulmonary fibrosis by up-regulating Snail expression.
Topics: Animals; Bleomycin; Epithelial-Mesenchymal Transition; Idiopathic Pulmonary Fibrosis; Proteins; Rats; Saponins; Signal Transduction; Smad3 Protein; Snail Family Transcription Factors; Transforming Growth Factor beta1; Triterpenes; Up-Regulation | 2020 |